Atlas Trials

Pathologic Stage III Esophageal Adenocarcinoma AJCC v8

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Pathologic Stage III Esophageal Adenocarcinoma AJCC v8

RecordFirmDate
Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery (NCT04391049)NRG Oncology2021-12-02
Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers (NCT04460937)National Cancer Institute (NCI)2021-04-09
NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer (NCT04615013)M.D. Anderson Cancer Center2020-11-23
A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma (NCT04111172)Thomas Jefferson University2020-11-10
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes (NCT04501913)City of Hope Medical Center2019-12-24
Use of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esophageal or Gastroesophageal Junction (GEJ) Adenocarcinoma (NCT04097028)Roswell Park Cancer Institute2019-12-20
Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes (NCT04183218)Mayo Clinic2019-09-23
Nutritional Supplementation in Reducing Complications in Patients With Locally Advanced Esophageal Cancer Undergoing Chemotherapy, Radiation Therapy, and/or Surgery (NCT04029857)M.D. Anderson Cancer Center2019-03-14
Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma (NCT03784326)M.D. Anderson Cancer Center2019-02-19
Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Adenocarcinoma (NCT03395847)M.D. Anderson Cancer Center2018-02-09

Track Pathologic Stage III Esophageal Adenocarcinoma AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.